Smad1 + Smad5 Antibody

Basic information

Name

Smad1 + Smad5 Antibody

size

0.1ml

Catalog number

bs-1619R

Price

263 €

Details & buy    

Extended information

Modification(s)

None

Cross reactivity

Human

French translation

anticorps

Gene ID number

4090, 4086

Concentration

1ug per 1ul

Immunogen range

405-440/465

Conjugation

Unconjugated

Target Antigen

Smad1 + Smad5

Also known as

Smad1 + Smad5 PAb

Category

Primary Antibodies

Subcellular location

Cytoplasm, Nucleus

Clone number

Polyclonal antibody

Clonality

Polyclonal antibody

Modification site(s)

Unmodified antibody

Tested Applications

WB, IHC-P, IF(IHC-P)

Purification method

This antibody was purified via Protein A.

Long name

Smad1 + Smad5 Primary Polyclonal Antibody

Recommended dilutions

WB(1:100-1000), IHC-P(1:100-500), IF(IHC-P)(1:50-200)

Specificity

This is a highly specific antibody against Smad1 + Smad5.

Cross reactive species details

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

Synonym names

Mothers against decapentaplegic homolog 5; SMAD5; Mothers against decapentaplegic homolog 1; SMAD1

Source

This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Smad 5

Storage conditions

Keep the antibody in aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for up to 1 year.

Properties

If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Background of the target antigen

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD). Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.